AB Sciex, Alturas Partner on Workflows for Dried Blood Spot Analysis | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – AB Sciex and Alturas Analytics today announced a deal combining technologies from both firms to drive adoption of dried blood spot analysis for drug discovery and development.

Under the terms of the deal, Alturas scientists will use AB Sciex's QTrap 5500 mass spectrometry platform and novel microflow chromatography technology from AB Sciex's Eksigent business to build out workflows for dried blood spot analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.